Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Weili Zhao, MD,PhD
CONTACT
Zixun Yan, MD,PhD
CONTACT
Lead
Guangdong Ruishun Biotech Co., Ltd
With
The study was based on an accelerated titration and "3+3" design with a dose-escalation phase and a dose-expansion phase, and was designed to assess the safety, maximum tolerated dose, pharmacokinetic profile, and initial efficacy of RJMty19 in subjects with r/r B-NHL after second-line treatment or above.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted